Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism
NCT01004939
·
clinicaltrials.gov ↗
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Thromboembolism
Venous Thromboembolism
Interventions
DRUG:
fondaparinux
Sponsor
GlaxoSmithKline